As this finding pertained to patients without preexisting cognitive impairment, severe mental illness or those diagnosed with delirium, which are known predisposing factors for cognitive decline [7–9], serum neuropeptide galanin levels may be a potentially valuable biomarker for improved prediction of cognitive decline after hip fracture. This evidence concerns the gene GAL and delirium.